Makiko Kawaguchi

7PUBLICATIONS
9CO-AUTHORS
Neural engineeringPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical devicesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 29, 2025
Engineered Expression of Hepatocyte Growth Factor Activator Inhibitor-1 (HAI-1) Reduces the Growth of Bladder Cancer Cells.

Yuichi Katayama, Takahiro Akioka, Shoichi Kimura

|Apr 29, 2025
Phosphorylation of MET Is Upregulated in Metastatic Sites of Renal Cell Carcinoma: Possible Role of MET and Hepatocyte Growth Factor Activation-Targeted Combined Therapy.

Takahiro Akioka, Shoichi Kimura, Yuichi Katayama

|Mar 13, 2025
Combined Therapy Targeting MET and Pro-HGF Activation Shows Significant Therapeutic Effect Against Liver Metastasis of CRPC.

Shoichi Kimura, Satoshi Iwano, Takahiro Akioka

|Dec 28, 2024
Loss of hepatocyte growth factor activator inhibitor type 1 (HAI-1) upregulates MMP-9 expression and induces degradation of the epidermal basement membrane.

Liang Weiting, Makiko Kawaguchi, Tsuyoshi Fukushima

|Aug 04, 2023
Early-onset tufting enteropathy in HAI-2-deficient mice is independent of matriptase-mediated cleavage of EpCAM.

Roman Szabo, Makiko Kawaguchi, Hiroaki Kataoka

|Feb 17, 2023
Adrenomedullin alleviates mucosal injury in experimental colitis and increases claudin-4 expression in the colonic epithelium.

Makiko Kawaguchi, Hiroaki Kataoka, Takumi Kiwaki

Pageof 2

Frequent Collaborators

6 joint publications

Tsuyoshi Fukushima

4 joint publications

Hiroaki Kataoka

3 joint publications

Shoichi Kimura

2 joint publications

Takumi Kiwaki